Chronic lung disease of prematurity: 10 years follow-up using clinical parameters and MR imaging – initial results

S. Ley, J. Ley-Zaporozhan, F. M. Müller, J. Pöschl (Heidelberg, Germany)

Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Session: Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Session type: E-Communication Session
Number: 1728

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ley, J. Ley-Zaporozhan, F. M. Müller, J. Pöschl (Heidelberg, Germany). Chronic lung disease of prematurity: 10 years follow-up using clinical parameters and MR imaging – initial results. Eur Respir J 2009; 34: Suppl. 53, 1728

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011

Severe COVID-19 pneumonia: clinical, functional, and imaging outcomes at 4 months
Source: Virtual Congress 2021 – Chronic COVID - 19
Year: 2021



Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Scottish pulmonary sarcoidosis – an exploratory analysis of prevalence, presentation and clinical data in nearly 200 patients
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009

Advanced pulmonary sarcoidosis: long-term follow-up of 10 years or more.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018




COPD comorbidities – Do they add more cost? A 1-year follow-up study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012


Predictors for developing hypoxic respiratory failure in COPD – A 3-year follow-up
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011


Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Lymphangioleiomyomatosis – Clinical characteristics and longitudinal follow-up of 36 cases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011


Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

Interstitial lung diseases in children – Clinical and pathological characteristics
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Value of proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD: Initial experience
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Late Breaking Abstract: Pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF) in early course of disease – A prospective evaluation with right heart catheterization (RHC) in the ARTEMIS-IPF study
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010

Pulmonary sequelae in patients with COVID-19: results after 3 months of follow-up
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021

Pulmonary tuberculosis presentation – Late diagnosis, advanced disease
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012


The journey to severe obstructive lung disease – Retrospective study of FEV1 decline
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012


Clinical parameters for predicting 3-month FEV1 response of obstructive lung diseases in elderly patients
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

Six minute walk test (6MWT) in patients with diagnosis of lung cancer – Clinical value in physiological evaluation candidates for surgical treatment
Source: Annual Congress 2012 - Pre-operative evaluation in thoracic surgery
Year: 2012


Imaging and functional disorders in occupational bronchiolitis, follow-up 1,7 years
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019


Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011